Smoking is bad for virtually every type of arthritis. It raises the risk of developing rheumatoid arthritis, accelerates cartilage loss in osteoarthritis, makes medications less effective, and worsens disease activity across the board. The effects are not minor: smokers with rheumatoid arthritis face roughly double the odds of poor treatment response, and smokers with knee osteoarthritis lose cartilage up to 2.5 times faster than nonsmokers.
Smoking and Rheumatoid Arthritis Risk
The link between smoking and rheumatoid arthritis (RA) is one of the strongest environmental risk factors in all of rheumatology. Men who have ever smoked are about 1.9 times more likely to develop seropositive RA, the form marked by specific antibodies in the blood. For women, the risk is lower but still elevated at roughly 1.3 times that of never-smokers.
The numbers climb sharply for a specific subtype. Men who currently smoke are nearly four times more likely to develop RA that tests positive for rheumatoid factor, a key marker of more aggressive disease. Even former male smokers carry about 2.5 times the risk. These aren’t small increases; they place smoking alongside genetics as one of the most important predictors of who develops RA.
How Smoking Triggers Joint Inflammation
The connection isn’t just statistical. There’s a clear biological pathway that starts in your lungs and ends in your joints. When cigarette smoke contacts the tissue lining your airways, especially the trachea, it triggers a chemical change called citrullination. This is a process where certain proteins get altered in a way the immune system doesn’t recognize. Your body then produces antibodies against these modified proteins, known as anti-CCP antibodies, which are a hallmark of rheumatoid arthritis.
In animal studies, exposure to cigarette smoke accelerated the onset of arthritis by two weeks compared to unexposed groups. The smoke-exposed animals showed significantly elevated anti-CCP antibodies in their blood and widespread citrullination not only in lung tissue but also in their joints. The tracheal cartilage, which takes the first hit from inhaled smoke, showed the most intense protein changes. This suggests the lungs act as a launchpad: smoking starts an immune reaction in the airways that eventually spills over into the joints.
Worse Symptoms for Smokers With RA
If you already have rheumatoid arthritis, smoking makes it harder to control. Disease activity scores tell the story clearly. In one study tracking patients over 30 months, smokers had a clinical disease activity score of 16.67 compared to 12.05 for nonsmokers, even after adjusting for other factors. That gap represents the difference between moderate and low disease activity, which in practical terms means more swollen joints, more pain, and more difficulty with daily tasks. Depression, which is more common in smokers, did not account for this difference. The effect held even after controlling for it.
Smoking Makes Arthritis Medications Less Effective
One of the more frustrating effects of smoking is that it undercuts the medications meant to treat RA. Current smokers are about twice as likely to have an inadequate response to methotrexate, the most commonly prescribed first-line treatment for RA. Their odds of achieving a good treatment response at three months are roughly 40% lower than nonsmokers on the same drug. By six months, the pattern is similar, with smokers about 42% less likely to reach a good response and 59% less likely to achieve remission.
This means smokers with RA often need to escalate to more expensive or more potent treatments sooner, and the underlying inflammation may still be harder to tame. Past smoking, notably, did not carry the same penalty. The interference appears tied to active smoking.
Osteoarthritis Gets Worse Too
Smoking’s effects aren’t limited to autoimmune forms of arthritis. In men with knee osteoarthritis, current smokers were 2.3 times more likely to lose cartilage in the main weight-bearing part of the knee and 2.5 times more likely to lose cartilage behind the kneecap. These odds were adjusted for age, body weight, and how much cartilage was already gone at the start of the study.
Pain tells the same story. Smokers with knee osteoarthritis reported pain scores about 30% higher than nonsmokers, both at the beginning of the study and at follow-up. On a 0-to-100 pain scale, smokers averaged around 60 while nonsmokers averaged around 44. That gap persisted over time, suggesting smoking doesn’t just flare things up temporarily but keeps pain levels chronically elevated.
Spinal Arthritis and Smoking
For people with ankylosing spondylitis, a type of inflammatory arthritis that primarily affects the spine, smoking doubles the odds of cumulative structural damage. A meta-analysis combining data from eight studies found that smokers had 2.0 times the odds of significant spinal damage compared to nonsmokers. This damage takes the form of new bone growth between vertebrae, which can eventually fuse sections of the spine together and permanently limit mobility. Smoking is also associated with higher disease activity scores, worse physical function, and lower quality of life in these patients.
Secondhand Smoke Carries Risk
You don’t have to smoke yourself to be affected. A meta-analysis of six studies found that passive smoke exposure raises the risk of developing RA by about 12%. The risk is higher for people exposed during childhood, where the increase reaches 34%. This is particularly relevant for parents and caregivers: children growing up in smoking households may carry an elevated risk of RA decades later, long after the exposure ends.
What Happens After Joint Replacement
Many people with severe arthritis eventually need a hip or knee replacement, and smoking affects surgical outcomes as well. In a study of over 117,000 patients, smokers had a significantly higher risk of lung infections after both hip and knee replacement surgery, along with a higher risk of heart attack after hip replacement. The good news is that long-term implant survival was similar across smokers, former smokers, and nonsmokers, with no increased risk of needing revision surgery over 20 years. So while the implant itself holds up, the recovery period is riskier.
Benefits of Quitting
Immune function begins improving as early as two months after quitting. For people with ankylosing spondylitis, a study following patients over six months found that those who quit smoking saw significant improvements in disease activity, physical function, pain levels, quality of life, and even lung capacity compared to those who kept smoking. These weren’t subtle shifts; they showed up across nearly every measure the researchers tracked.
Quitting also restores the effectiveness of RA medications. Since the reduced treatment response is linked to current smoking rather than a history of smoking, stopping appears to remove that barrier. Former smokers in treatment studies performed similarly to people who had never smoked. The elevated risk of developing RA does persist for years after quitting, but the benefits for disease control, pain, physical function, and surgical safety begin much sooner.